N/A N=57 Laparoscopic Adjustable Gastric Banding in Adolescents
Morbid Obesity
Primary: Total Weight Loss — 11.35 kilograms
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=37 A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
Open-Angle Glaucoma · Ocular Hypertension
Primary: Change From Baseline in Time-Matched Intraocular Pressure (IOP) for Bimatoprost SR Treated Eyes — -3.7; -4.0; -2.5; -3.2 Millimeters of Mercury (mmHg)
Phase 2 N=201 ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19
COVID-19
Primary: Number of Participants Meeting Criteria for Each of the 8 Ordinal Scale Categories on Day 8 — 11; 15; 24; 28 Participants — p=0.090
N/A N=75 Safety and Effectiveness of the Qualis Contact Lens
Refractive Errors
Primary: Number of Eyes With Non-Serious Adverse Reactions — 1; 3; 7; 0 eyes
N/A N=110 Neonatal Sleep Intervention to Improve Postpartum Hypertension
Pre-Eclampsia · Gestational Hypertension · Sleep
Primary: Mean Arterial Pressure — 93; 94 mm Hg — p=0.54
Phase 4 N=37 Responses to Rabies Vaccine in Adults With or Without Antibiotics
Rabies Human
Primary: Antibody Titers — 217.39; 805.64 IU/mL
N/A N=17 Providing Suboxone and PrEP Using Telemedicine
Opioid Use · Opioid-use Disorder · Risk Reduction
Primary: Number of Participants Who Demonstrate no or Minimal Opioid Use at 3 Months — 6 Participants
N/A N=13 Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS
Amyotrophic Lateral Sclerosis
Primary: Change From Baseline to Post-treatment for Maximum Expiratory Pressure — 66.10; 83.75 cmH2O — p=.001
N/A N=12 Study of Humidified Air to Improve Mucociliary Clearance (MCC) in COPD
COPD
Primary: Mucociliary Clearance Rate - 4 Hours — 47; 56 percent clearance — p=0.11
N/A N=10 Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
Stroke, Acute
Primary: Safety Outcome: Rate of Symptomatic Intracranial Hemorrhage (SICH) in the Active Treatment Arms Compared to Sham Arm — 0; 1; 0 Participants
Phase 3 N=515 Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?
Sinusitis · Respiratory Tract Infections
Primary: The Mean Pediatric Rhinosinusitis Symptom Scale (PRSS) Score Over the First 10 Days of Follow-up According to the Presence of Pathogens in the Nasopharynx at Enrollment…
Phase 4 N=5 Shoulder Contraceptive Implant Study
Contraception
Primary: Pharmacokinetics in the Form of Serum Etonogestrel Concentrations — 511.7; 136.6 pg/mL
Phase 3 N=804 Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Head and Neck Neoplasms
Primary: Event-free Survival (EFS) — NA; 46.6 Months — p=0.0429
Phase 2 N=44 Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)
Age-Related Macular Degeneration
Primary: Number of Subjects With No Cells Observed Following Slit Lamp Examination From Baseline to Week 8 — 23; 21; 23; 21 Participants
Phase 2 N=16 Neuromyelitis Optica (NMO) & Cetirizine
Neuromyelitis Optica
Primary: Annualized Relapse Rate Before Cetirizine — 0.4; 0.1 relapses per year